Literature DB >> 25666019

Benzodiazepine exposure increases risk of Alzheimer's disease.

Paul B Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25666019     DOI： 10.1136/ebmed-2014-110117

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  6 in total

Review 1.  Treatment of Sleep Disorders in Dementia.

Authors:  Sharon Ooms; Yo-El Ju
Journal:  Curr Treat Options Neurol       Date:  2016-09       Impact factor: 3.598

2.  Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

Authors:  Shanna L Burke; Janice O'Driscoll; Amary Alcide; Tan Li
Journal:  Int J Geriatr Psychiatry       Date:  2016-11-02       Impact factor: 3.485

3.  Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease.

Authors:  Kavon Javaherian; Brianne M Newman; Hua Weng; Jason Hassenstab; Chengjie Xiong; Dean Coble; Anne M Fagan; Tammie Benzinger; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jan-Mar       Impact factor: 2.703

4.  Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice.

Authors:  Tomonori Furukawa; Yoshikazu Nikaido; Shuji Shimoyama; Nozomu Masuyama; Ayaka Notoya; Shinya Ueno
Journal:  Front Aging Neurosci       Date:  2021-11-26       Impact factor: 5.750

5.  Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study.

Authors:  Michael Liebrenz; Marcel Schneider; Anna Buadze; Marie-Therese Gehring; Anish Dube; Carlo Caflisch
Journal:  Harm Reduct J       Date:  2016-01-08

Review 6.  Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies.

Authors:  Elena Urrestarazu; Jorge Iriarte
Journal:  Nat Sci Sleep       Date:  2016-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.